HomeNewsTrendsCurrent AffairsDelhi lockdown: Here’s a look at how cases have surged in the national capital

Delhi lockdown: Here’s a look at how cases have surged in the national capital

As COVID-19 cases in Delhi surge, impelling the government to announce a 6-day lockdown. Here's a look at the COVID-19 situation in the national capital amidst the rising second wave.

April 19, 2021 / 17:49 IST
Story continues below Advertisement
A patient suffering from the coronavirus disease (COVID-19) is wheeled from the casualty ward in Lok Nayak Jai Prakash (LNJP) hospital, amidst the spread of the disease in New Delhi, India April 15, 2021. REUTERS/Danish Siddiqui - RC2AWM9NQQUJ
A patient suffering from the coronavirus disease (COVID-19) is wheeled from the casualty ward in Lok Nayak Jai Prakash (LNJP) hospital, amidst the spread of the disease in New Delhi, India April 15, 2021. REUTERS/Danish Siddiqui - RC2AWM9NQQUJ

Amidst rising COVID-19 cases, the Delhi government has announced lockdown in the national capital from 10.00 pm on April 19 to 6.00 am on April 26.

With 25,462 new cases, Delhi recorded an all-time high as per April 19 update. It also reported the third highest fresh cases in the country after Maharashtra (68,631) and Uttar Pradesh (30,566).

Chief Minister Arvind Kejriwal on Monday said that the six-day lockdown period will be used to arrange oxygen, medicines and add more beds in Delhi. Of the 17,514 hospital beds for COVID-19 management in Delhi, 79 percent or 13,887 have been occupied, as per the Delhi government’s health update on April 18. 

Story continues below Advertisement

The government also has 5,525 dedicated COVID Care Centre beds, of which 558 or 10 percent are occupied; 132 beds under COVID Health Centre of which 96 beds have been occupied. While more than 34,000 people are under home isolation. 

At present Delhi has 74,941 active cases as per April 19 update, sixth highest in the country. While 2,565,918 vaccination doses have been administered till date. Of these, 82 percent are recipients of their first dose and 17 percent have received their second dose.